Voyager Therapeutics, Inc. ( VYGR) - Key Metrics
VYGR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.26 | -$0.47 | -$0.52 | -$0.53 |
| 2025Q3 | $0.23 | -$0.47 | -$0.53 | -$0.53 |
| 2025Q2 | $0.09 | -$0.57 | -$0.57 | -$0.59 |
| 2025Q1 | $0.11 | -$0.53 | -$0.65 | -$0.66 |
VYGR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -2.10 |
| 2025Q3 | ? | -2.46 |
| 2025Q2 | ? | -1.37 |
| 2025Q1 | ? | -1.59 |
VYGR
Price: $3.10
52 week price:
Earnings Per Share: -1.98 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 275000
Ebitda: -22.9 millionMarket Capitalization: 218.7 million